Porras-Quesada, P.; Chica-Redecillas, L.; Álvarez-González, B.; Gutiérrez-Tejero, F.; Arrabal-Martín, M.; Rios-Pelegrina, R.; Martínez-González, L.J.; Álvarez-Cubero, M.J.; Vázquez-Alonso, F.
GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate Cancer. Biomedicines 2025, 13, 1872.
https://doi.org/10.3390/biomedicines13081872
AMA Style
Porras-Quesada P, Chica-Redecillas L, Álvarez-González B, Gutiérrez-Tejero F, Arrabal-Martín M, Rios-Pelegrina R, Martínez-González LJ, Álvarez-Cubero MJ, Vázquez-Alonso F.
GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate Cancer. Biomedicines. 2025; 13(8):1872.
https://doi.org/10.3390/biomedicines13081872
Chicago/Turabian Style
Porras-Quesada, Patricia, Lucía Chica-Redecillas, Beatriz Álvarez-González, Francisco Gutiérrez-Tejero, Miguel Arrabal-Martín, Rosa Rios-Pelegrina, Luis Javier Martínez-González, María Jesús Álvarez-Cubero, and Fernando Vázquez-Alonso.
2025. "GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate Cancer" Biomedicines 13, no. 8: 1872.
https://doi.org/10.3390/biomedicines13081872
APA Style
Porras-Quesada, P., Chica-Redecillas, L., Álvarez-González, B., Gutiérrez-Tejero, F., Arrabal-Martín, M., Rios-Pelegrina, R., Martínez-González, L. J., Álvarez-Cubero, M. J., & Vázquez-Alonso, F.
(2025). GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate Cancer. Biomedicines, 13(8), 1872.
https://doi.org/10.3390/biomedicines13081872